NCT06010589

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers

Bioequivalence Study to Compare the Pharmacokinetics and Safety Following Administration of DWJ1558 and Co-administration of DWC202310 and DWC202311 in Healthy Volunteers

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

This study aims to compare the pharmacokinetics and safety following administration of DWJ1558 and co-administration of DWC202310 and DWC202311 in healthy volunteers.

Conditions

• Healthy Volunteers

Interventions

Type	Name	Description
DRUG	DWJ1558	DWJ1558
DRUG	DWC202310 and DWC202311	Co-administration of DWC202310 and DWC202311

Timeline

• Start date: 2023-08-17
• Primary completion: 2024-01-01
• Completion: 2024-01-01
• First posted: 2023-08-24
• Last updated: 2023-08-30

Locations

1 site across 1 country: South Korea